Navigation Links
Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

d as a single agent for patients who are intolerant to irinotecan-based therapy. The effectiveness of ERBITUX for the treatment of EGFR-expressing mCRC is based on objective response rates. Currently, no data are available that demonstrate an improvement in disease-related symptoms or increased survival with ERBITUX for the treatment of EGFR-expressing mCRC.

For full prescribing information, including boxed WARNINGS regarding infusion reactions and cardiopulmonary arrest, visit http://www.ERBITUX.com.

Important Safety Information

Grade 3/4 infusion reactions, rarely with fatal outcome (less than 1 in 1000), occurred in approximately 3% (46/1485) of patients receiving ERBITUX (Cetuximab) therapy. These reactions are characterized by rapid onset of airway obstruction (bronchospasm, stridor, hoarseness), urticaria, hypotension, and/or cardiac arrest. Severe infusion reactions require immediate and permanent discontinuation of ERBITUX therapy.

Most reactions (90%) were associated with the first infusion of ERBITUX despite the use of prophylactic antihistamines. Caution must be exercised with every ERBITUX infusion as there were patients who experienced their first severe infusion reaction during later infusions. A 1-hour observation period is recommended following the ERBITUX infusion. Longer observation periods may be required in patients who experience infusion reactions.

Cardiopulmonary arrest and/or sudden death occurred in 2% (4/208) of patients with squamous cell carcinoma of the head and neck treated with radiation therapy and ERBITUX as compared to none of 212 patients treated with radiation therapy alone. Fatal events occurred within 1 to 43 days after the last ERBITUX treatment. ERBITUX in combination with radiation therapy should be used with caution in patients with known coronary artery disease, congestive heart failure and arrhythmias. Close monitoring of serum electrolytes, including serum magnesium, potassium, and calci
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:7/27/2015)... , July 20, 2015 Research ... addition of the "D-dimer Testing Market - ... and Forecast 2014 - 2022" report to ... in vitro diagnostics market is one of the ... be attributed to the improved health care awareness, ...
(Date:7/27/2015)... , July 17, 2015 Research and ... of the "G-Protein Coupled Receptors Market: Global ... 2014 - 2022" report to their offering. ... been segmented based on of assay type, therapeutic ... GPCRs market has been categorized into six major ...
(Date:7/27/2015)... , July 27, 2015 Bloomage BioTechnology ... announces a strategic cooperation with the South Korean BioTech ... a joint venture Medybloom to develop and promote Type ... China . Medytox, the Botulinum ... and is also the fourth company in the world ...
Breaking Medicine Technology:D-dimer Testing Market - Global Industry Analysis 2015 2D-dimer Testing Market - Global Industry Analysis 2015 3G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3
(Date:7/27/2015)... ... 27, 2015 , ... Interactive health education is a highly ... Wound Care Advantage beta launched Luvo University, an online learning management ... learning paths allow for clinicians, physicians, hyperbaric technicians and non-clinical staff to get ...
(Date:7/27/2015)... ... July 27, 2015 , ... Writing Effective ... Aug. 13, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/writingeffectivesops ... FDA investigators will look at during an inspection. Yet, in 2014, "inadequate ...
(Date:7/27/2015)... ... , ... In a piece published July 22 on LinkedIn’s Pulse, ... explained why people should not shy away from their own personal aspirations. The author ... and celebrate it for the modern wonder that it is.” This is a great ...
(Date:7/27/2015)... ... ... Looking to brush up on all the things you should be doing ... enhanced its Dental webpage with new materials, including user-friendly, educational videos, to help members ... to offering our 3.8 million members tools and resources to help them keep a ...
(Date:7/27/2015)... TX (PRWEB) , ... July 27, 2015 , ... North ... of 2015. , The center invites all those prospective joint-replacement patients, along with ... and Thursday of each month, with Monday classes (Aug 6, Sept 8 [Tue due ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 2Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 3Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 4Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2
... cases of bird flu, the chief state epidemiologist Gennady ... the sixth country where the deadly H5N1 bird flu virus ... outside eastern Asia. ,"I earnestly advise Russian citizens ... province of Agri and the city of Dogubayazit where the ...
... year. The need the organ, kidney is on the rise and ... all the organ transplantations done, kidney transplantation accounts for 64%. But ... the number of people who come forward to donate organs especially ... to undergo kidney transplants has widened to more than four years. ...
... Chief of the Specialty Hospital in the United States, ... a shot in the arm.//Specialty Hospitals thought of as ... was nipped in the bud, owing to vested interests ... The Wall Street Journal, has expressed disappointment at the ...
... can be detected years before the symptoms even appear, according ... the size of two parts of the brain, according to ... Those with a smaller hippocampus or amygdala are much more ... General Psychiatry. ,Both parts decline in size ...
... Alarming reports of AIDS patients being robbed off their pockets ... shift in the service based health care system, // believed ... ,Cai had no AIDS related symptoms when she was admitted ... she had, ensured prompt medical attention at the time of ...
... A considerable improvement in the oral feeding habits of ... 11 days following institution of feeding facilitating techniques. // ... been the use of a feeding tube. Prolonged use ... risk for development of gastroesophageal reflux. With the introduction ...
Cached Medicine News:Health News:Russia warns against travel to Turkey, Iran closes border 2Health News:AIDS Patients Deceived By Private Health Care System In China 2Health News:New Technique Enables Better Nursing Of Robin Sequence Infants 2
Rapid assay, results in 1 hours,Assay sensitivity of 1.14 ng/mL...
... IMMULITE 1000 assays are designed ... and IMMULITE 1000, continuous random ... simplicity in both design and ... found in a wide variety ...
... digital x-ray detectors from KUBTEC represents a ... 12 to 16 bit digital interface. The ... array sensor with pixel spacing down to ... low x-ray energies (10-50 kV) and an ...
... from KUBTEC is a dual capability system with ... representation of the specimen under test. While the ... images, the micro focus source also allows the ... standard 2D images. The 100 mm x 100 ...
Medicine Products: